Midkine promotes glioblastoma progression via PI3K-Akt signaling.
Beiquan HuChao QinLi LiLei WeiXianlun MoHuasheng FanYuanhua LeiFeng WeiDong-Hua ZouPublished in: Cancer cell international (2021)
Our present study proposes that MDK promotes GBM by activating the PI3K-Akt signaling pathway, and it describes a potential regulatory network involved.